We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
In October 2011 the NHS National Quality Board (NQB) agreed on a working definition of patient experience to guide the measurement of patient experience across the NHS.
How to use a cost consequence analysis to evaluate your digital health product.
A summary of what delivering better integrated care means and how Monitor is supporting the sector.
The review of the safety of isotretinoin has concluded.
Consumers and patient groups are invited to submit evidence of their experience
Work is ongoing to address the comments and feedback from respondents to the consultation. Publication of our report on the consultation has been delayed in light of the Agency’s response during the ongoing coronavirus situation.
Using an ecological momentary assessment to evaluate your digital health product.
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
This national report provides insights into the care experienced by cancer patients across England who were treated as day cases or inpatients during the first three months of 2010.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
The Wellcome Trust has funded a 3-year project focusing on effective regulation and evaluation of digital mental health technology.
This page brings together government's work and announcements on loneliness.
This document explains: how patients are tested and treated, and steps in place to prevent its spread.
This guidance contains sources of support available to sponsors.
Statistics from the Department of Health on how patients experience care in the NHS in England, updated to include results from the 2011 inpatient survey.
Patients requiring treatment outside of hospitals will be able to choose between multiple providers across the NHS and independent sector.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).